Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2014
08/28/2014WO2014130811A1 Interferon beta formulation
08/28/2014WO2014130761A2 Nanostructured active therapeutic vehicles and uses thereof
08/28/2014WO2014130429A2 Caged platinum nanoclusters for anticancer chemotherapeutics
08/28/2014WO2014130204A1 Personal care compositions comprising anionic surfactants and hydrophobic actives
08/28/2014WO2014128661A1 Oral formulation and suspension of an oncology drug
08/28/2014WO2014128497A1 Therapeutics for suppressing osteoporosis
08/28/2014WO2014128225A1 Activation of inkt cells
08/28/2014WO2014127802A1 Stable compositions of bendamustine
08/28/2014WO2014127459A1 Pharmaceutical composition for enhanced transmucosal administration of benzodiazepines
08/28/2014WO2014127458A1 Pharmaceutical composition for transmucosal administration of benzodiazepines
08/28/2014WO2014093696A3 Insulin derivatives for diabetes treatment
08/28/2014WO2014089335A3 Bcma antigen binding proteins
08/28/2014WO2014081343A3 Pharmaceutical composition containing nalbuphine hydrochloride, use thereof to treat moderate to severe pain and method for producing said pharmaceutical composition
08/28/2014WO2013126590A8 Pharmaceutical composition comprising cd34+ cells
08/28/2014US20140243765 Percutaneously absorbable preparation containing fentanyl and homologue thereof
08/28/2014US20140243664 Polymeric Nanoparticles for Ultrasound Imaging and Therapy
08/28/2014US20140243430 Orally bioavailable lipid-based constructs
08/28/2014US20140243429 Enzyme-Degradable Polymer and Application Thereof
08/28/2014US20140243428 Self healing hydrogels
08/28/2014US20140243427 Process for Preparing a Synthetic Foam Having a Controlled Particle Distribution
08/28/2014US20140243426 Composition for cryopreservation of cells and tissues
08/28/2014US20140243425 Controlled release compositions for modulating free-radical induced damage and methods of use thereof
08/28/2014US20140243413 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
08/28/2014US20140243395 Spray system for production of a matrix formed in situ
08/28/2014US20140243391 Phospholipid-detergent conjugates and uses thereof
08/28/2014US20140243379 Adhesive mixture for transdermal delivery of highly plasticizing drugs
08/28/2014US20140243300 Controlling the Bioavailability of Active Ingredients in Topical Formulations
08/28/2014US20140243282 Methods and compositions for designing novel conjugate therapeutics
08/28/2014US20140243258 Methods and compositions for targeting adipose cells in mammals
08/28/2014US20140243254 Polymeric Hyperbranched Carrier-Linked Prodrugs
08/28/2014US20140242666 Vaccine for shigella
08/28/2014US20140242193 Lithium compositions
08/28/2014US20140242186 Guided bone regeneration membrane and manufacturing method thereof
08/28/2014US20140242182 Formulations that stabilize proteins
08/28/2014US20140242180 Nanoparticles for controlling bleeding and drug delivery
08/28/2014US20140242177 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
08/28/2014US20140242171 Oil-in-water emulsion of mometasone and propylene glycol
08/28/2014US20140242166 Sustained release matrix systems for highly soluble drugs
08/28/2014US20140242161 Soft gelatin capsules
08/28/2014US20140242146 Filament based on hyaluronic acid in the form of free acid and method for obtaining it
08/28/2014US20140242145 Chitosan nanofiber for anionic protein drug delivery, method of preparing the same, and pharmaceutical preparation for transmucosal administration comprising the chitosan nanofiber
08/28/2014US20140242125 Muscle tissue regeneration using muscle fiber fragments
08/28/2014US20140242123 Saccharide-peptide hydrogels
08/28/2014US20140242117 Vaccine Composition Capable of Inducing Memory Antibody Response from Single Point Immunization
08/28/2014US20140242113 Liquid vaccine preparations
08/28/2014US20140242108 Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists
08/28/2014US20140242097 Methods
08/28/2014US20140242096 Compositions and methods related to graft versus host disease and treatments thereof
08/28/2014US20140242066 Formulation and treatment for acne
08/28/2014US20140242057 Conjugated factor viii molecules
08/28/2014US20140242051 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof
08/28/2014US20140242035 Methods and systems for treating cell proliferation disorders
08/28/2014US20140242023 Topical Compositions and Methods of Using the Same
08/28/2014US20140242018 Liquid non-ionic salt-free skin and hair treatment composition that contains n-methyl lauroyl glucamide
08/28/2014US20140241999 Peptide linkers for effective multivalent peptide binding
08/28/2014US20140241997 Wound treatment
08/28/2014US20140239223 Method of making a formulation for deactivating nucleic acids
08/27/2014EP2770053A1 In vivo incorporation of alkynyl amino acids into proteins in eubacteria
08/27/2014EP2769990A2 Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
08/27/2014EP2769738A1 Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists
08/27/2014EP2769718A1 Medicinal composition
08/27/2014EP2769713A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol
08/27/2014EP2769711A1 Methods and Compositions for Enhanced Delivery of Macromolecules
08/27/2014EP2768537A2 Acrylic polymer formulations
08/27/2014EP2768522A1 Use of sulfated glycosaminoglycans for improving the bioavailability of factor viii
08/27/2014EP2768521A1 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii
08/27/2014EP2768508A1 Solution for oral administration
08/27/2014EP2768492A2 Compounds, compositions, and methods for reducing or eliminating bitter taste
08/27/2014EP2768490A1 Stabilizers for hemostatic products
08/27/2014EP2768488A1 Two phase pharmaceutical delivery system
08/27/2014EP2768485A1 Pharmaceutical nanosuspension
08/27/2014EP2768482A1 Anti-tumoral compound and relative production process
08/27/2014EP2768478A1 Paste comprising non-steroidal anti-inflammatory
08/27/2014EP2768477A1 Nicotine chewing gum with improved utilization of nicotine
08/26/2014US8816066 Cellulose interpolymers and methods of oxidation
08/26/2014US8816051 Conjugated biological molecules and their preparation
08/26/2014US8816002 Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
08/26/2014US8816001 Genetically encoded initiator for polymer growth from proteins
08/26/2014US8815959 Oil-in-water emulsion composition and method for producing same
08/26/2014US8815944 Pharmaceutical composition with gelling properties containing a tyrosine derivative
08/26/2014US8815937 Lipoyl compounds and their use for treating ischemic injury
08/26/2014US8815912 Wound and mucosa antiseptic based on bispyridiniumalkanes
08/26/2014US8815838 Aerosol fluoroquinolone formulations for improved pharmacokinetics
08/26/2014US8815804 Methods and compositions related to targeting tumors and wounds
08/26/2014US8815801 Controlled release composition and method of producing the same
08/26/2014US8815311 Methods for improving thyroid function in a subject
08/26/2014US8815301 Stable iron oligosaccharide compound
08/26/2014US8815293 Organic compounds
08/26/2014US8815289 Tamper resistant dosage forms
08/26/2014US8815280 Nutritional intervention for improving muscular function and strength
08/26/2014US8815279 Baby feeding formula and system
08/26/2014US8815277 In situ forming hydrogel and biomedical use thereof
08/26/2014US8815261 Composition for external application comprising aripiprazole and organic acid as active ingredients
08/26/2014US8815255 Use of Mycoplasma bovis antigen
08/26/2014US8815250 Clotting factor-Fc chimeric proteins to treat hemophilia
08/26/2014US8815235 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
08/26/2014US8815228 Alloplastic injectable dermal filler and methods of use thereof
08/26/2014US8815226 Protein-polymer-drug conjugates
08/26/2014US8815212 Nanocarriers for imaging and therapy applications
08/26/2014CA2729819C Unit dosage of apadenoson
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 1712